Format

Send to

Choose Destination
Curr Infect Dis Rep. 2017 Sep 19;19(11):40. doi: 10.1007/s11908-017-0598-1.

Treatment of Aortic Graft Infection in the Endovascular Era.

Author information

1
Division of Vascular Surgery and Endovascular Therapy, The Johns Hopkins Hospital, Halsted 668 600 N Wolfe Street, Baltimore, MD, 21287, USA.
2
Division of Vascular Surgery and Endovascular Therapy, The Johns Hopkins Hospital, Halsted 668 600 N Wolfe Street, Baltimore, MD, 21287, USA. ylum@jhmi.edu.

Abstract

PURPOSE OF REVIEW:

This review provides an overview of the current literature surrounding the medical and surgical treatment of aortic graft infection with particular focus on the role of endovascular aortic grafts in the changing demographics and management of these infections.

RECENT FINDINGS:

Definitive therapy for aortic graft infection continues to include parenteral antibiotics and surgical explantation and revascularization procedures, which are historically vast operations and sources of significant operative stress. Surgical management has evolved to include more options for infection resistant in situ conduits, attempts at partial explantations, and use of endovascular therapy to temporize the urgent sequelae of these infections, such as aortoenteric fistula. Aortic graft infection continues to be a significant and morbid complication of graft placement even with the advent of endovascular therapy, and its treatment will only increase in difficulty as a more frail population has gained access to complex aortic repair. In the future, more flexible revascularization and partial explantation options are keys, along with long-term suppressive antibiotics where appropriate.

KEYWORDS:

Aortic graft infection; Aortoenteric fistula; Endovascular infection; Explantation; In situ reconstruction; Stent-graft infection

PMID:
28929289
DOI:
10.1007/s11908-017-0598-1

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center